Testing the Use of the Combination of Selumetinib and Olaparib or Selumetinib Alone Targeted Treatment for RAS Pathway Mutant Recurrent or Persistent Ovarian and Endometrial Cancers, A ComboMATCH Treatment Trial

Trial Title: Testing the Use of the Combination of Selumetinib and Olaparib or Selumetinib Alone Targeted Treatment for RAS Pathway Mutant Recurrent or Persistent Ovarian and Endometrial Cancers, A ComboMATCH Treatment Trial

NCT ID: NCT05554328

Condition: Recurrent Endometrial Carcinoma
Recurrent Fallopian Tube Carcinoma
Recurrent Ovarian Carcinoma
Recurrent Primary Peritoneal Carcinoma

Conditions: Official terms:
Carcinoma
Endometrial Neoplasms
Recurrence
Olaparib
Poly(ADP-ribose) Polymerase Inhibitors

Study type: Interventional

Study phase: Phase 2

Overall status: Recruiting

Study design:

Allocation: Randomized

Intervention model: Parallel Assignment

Primary purpose: Treatment

Masking: None (Open Label)

Intervention:

Intervention type: Procedure
Intervention name: Biopsy
Description: Undergo tumor biopsy
Arm group label: Arm I (selumetinib, olaparib)
Arm group label: Arm II (selumetinib)

Other name: BIOPSY_TYPE

Other name: Bx

Intervention type: Procedure
Intervention name: Biospecimen Collection
Description: Undergo blood collection
Arm group label: Arm I (selumetinib, olaparib)
Arm group label: Arm II (selumetinib)

Other name: Biological Sample Collection

Other name: Biospecimen Collected

Other name: Specimen Collection

Intervention type: Procedure
Intervention name: Bone Marrow Aspiration and Biopsy
Description: Undergo bone marrow aspiration or biopsy
Arm group label: Arm I (selumetinib, olaparib)
Arm group label: Arm II (selumetinib)

Intervention type: Procedure
Intervention name: Computed Tomography
Description: Undergo CT scan
Arm group label: Arm I (selumetinib, olaparib)
Arm group label: Arm II (selumetinib)

Other name: CAT

Other name: CAT Scan

Other name: Computed Axial Tomography

Other name: Computerized Axial Tomography

Other name: Computerized axial tomography (procedure)

Other name: Computerized Tomography

Other name: Computerized Tomography (CT) scan

Other name: CT

Other name: CT Scan

Other name: tomography

Intervention type: Procedure
Intervention name: Echocardiography
Description: Undergo ECHO
Arm group label: Arm I (selumetinib, olaparib)
Arm group label: Arm II (selumetinib)

Other name: EC

Intervention type: Procedure
Intervention name: Multigated Acquisition Scan
Description: Undergo MUGA
Arm group label: Arm I (selumetinib, olaparib)
Arm group label: Arm II (selumetinib)

Other name: Blood Pool Scan

Other name: Equilibrium Radionuclide Angiography

Other name: Gated Blood Pool Imaging

Other name: Gated Heart Pool Scan

Other name: MUGA

Other name: MUGA Scan

Other name: Multi-Gated Acquisition Scan

Other name: Radionuclide Ventriculogram Scan

Other name: Radionuclide Ventriculography

Other name: RNV Scan

Other name: RNVG

Other name: SYMA Scanning

Other name: Synchronized Multigated Acquisition Scanning

Intervention type: Drug
Intervention name: Olaparib
Description: Given PO
Arm group label: Arm I (selumetinib, olaparib)

Other name: AZD 2281

Other name: AZD-2281

Other name: AZD2281

Other name: KU 0059436

Other name: KU-0059436

Other name: KU0059436

Other name: Lynparza

Other name: Olanib

Other name: Olaparix

Other name: PARP Inhibitor AZD2281

Intervention type: Drug
Intervention name: Selumetinib Sulfate
Description: Given PO
Arm group label: Arm I (selumetinib, olaparib)
Arm group label: Arm II (selumetinib)

Other name: AZD-6244 Hydrogen Sulfate

Other name: AZD6244 Hydrogen Sulfate

Other name: AZD6244 Hydrogen Sulphate

Other name: Koselugo

Other name: Selumetinib Sulphate

Summary: This phase II ComboMATCH treatment trial compares selumetinib plus olaparib to selumetinib alone in women with endometrial or ovarian (fallopian tube and primary peritoneal) cancer that has come back (recurrent) or that remains despite treatment (persistent) and harbors a mutation in the RAS pathway. Selumetinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Olaparib is an inhibitor of PARP, an enzyme that helps repair deoxyribonucleic acid (DNA) when it becomes damaged. Blocking PARP may help keep tumor cells from repairing their damaged DNA, causing them to die. PARP inhibitors are a type of targeted therapy. The addition of olaparib to selumetinib could increase the percentage of tumors that shrink as well as lengthen the time that the tumors remain stable (without progression) as compared to selumetinib alone.

Detailed description: PRIMARY OBJECTIVES: I. Compare progression free survival of combination of olaparib and selumetinib sulfate (selumetinib) to selumetinib alone in patients with RAS mutant ovarian cancer. (Cohort 1) II. Compare progression free survival of combination of olaparib and selumetinib to selumetinib alone in patients with RAS mutant endometrial cancer. (Cohort 2) SECONDARY OBJECTIVES: I. Determine safety of both arms per Common Terminology Criteria for Adverse Events (CTCAE) version (v)5.0. II. Compare objective response rate per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1 between the two arms. III. Determine rate of objective response per RECIST 1.1 in those patients that crossover from the single agent arm to the combination arm. IV. Report duration of response of the two treatment arms. V. Collect tissue and provide it to the ComboMATCH Registration protocol to assess concordance between the diagnostic tumor mutation profile generated by the designated laboratories, the pre-treatment biopsy mutation profile, and the pre-treatment circulating tumor (ct)DNA mutation profile from plasma, as described in ComboMATCH Registration protocol. For this treatment substudy, the outcome objective will be to report the proportion of cases providing sufficient tissue for that integrated scientific activity in the ComboMATCH Registration protocol. TRANSLATIONAL OBJECTIVE: I. To assess association of baseline genomic and transcriptomic status with response and resistance to therapy. OUTLINE: Patients in both cohorts are randomized to 1 of 2 arms. ARM I: Patients receive selumetinib orally (PO) twice daily (BID) and olaparib PO BID on days 1-28. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity. Patients also undergo a tumor biopsy and blood collection during screening and on study, as well as echocardiogram (ECHO) or multigated acquisition (MUGA), and computed tomography (CT) scans throughout the trial. Patients may undergo bone marrow aspiration or biopsy as clinically indicated. ARM II: Patients receive selumetinib PO BID on days 1-28. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity. Patients who experience progression may elect to cross over to Arm I provided they have not had dose limiting toxicities to monotherapy selumetinib. Patients also undergo a tumor biopsy and blood collection during screening and on study, as well as ECHO or MUGA, and CT scans throughout the trial. Patients may undergo bone marrow aspiration or biopsy as clinically indicated. After completion of study treatment, patients are followed up every 3 months for 2 years and then every 6 months for 3 years.

Criteria for eligibility:
Criteria:
Inclusion Criteria: - Patient must have enrolled onto EAY191 and must have been given a treatment assignment to ComboMATCH to EAY191-N4 based on the presence of an actionable mutation as defined in EAY191 - Patients must be enrolled on the ComboMATCH Master Registration Trial EAY191 - Patients must have RAS pathway mutations as determined by the ComboMATCH screening assessment - Cohort 1: Patients with histologically confirmed RAS pathway mutant ovarian, primary peritoneal, or fallopian tube ("ovarian") cancer (activating mutations in KRAS, NRAS, HRAS, BRAF, MEK1, MEK2, or inactivating mutations in NF1) - Cohort 2: Patients with histologically confirmed RAS pathway mutant endometrial cancer (activating mutations in KRAS, NRAS, HRAS, BRAF, MEK1, MEK2, or inactivating mutations in NF1). - Patients must have disease that can be safely biopsied and agree to a pre-treatment biopsy, if disease cannot be safely biopsied, or have archival tissue available from within 12 months prior to registration on the ComboMATCH Registration Trial (EAY191) - Patients must have progressed after first-line treatment for recurrent or persistent disease - Patients with ovarian cancer should not be eligible for further platinum-based therapy - Patients with endometrial cancer must have received or been offered an immune oncology agent (alone or in combination with lenvatinib) unless there are existing contraindications for immune oncology agents or lenvatinib - Patients may have received unlimited prior therapy - Patients must have measurable and biopsiable disease. Measurable disease is defined by RECIST 1.1 as at least one lesion that can be accurately measured in at least one dimension (longest diameter to be recorded). Each lesion must be > 10 mm when measured by CT, magnetic resonance imaging (MRI) or caliper measurement by clinical exam; or > 20 mm when measured by chest x-ray. Lymph nodes must be > 15 mm in short axis when measured by CT or MRI - Patients must have at least one "target lesion" separate from the lesion to be biopsied to be used to assess response on this protocol as defined by RECIST version 1.1. Tumors within a previously irradiated field will be designated as "non-target" lesions unless progression is documented or a biopsy is obtained to confirm persistence at least 90 days following completion of radiation therapy - Prior therapy must have been completed at least four weeks prior to registration - Age >= 18 - Eastern Cooperative Oncology Group (ECOG) Performance Status of 0, 1 or 2 - Hemoglobin (Hgb) >= 9.5 g/dL with no blood transfusion in the past 28 days (within 14 days prior to registration) - Platelets >= 100,000/mcl (within 14 days prior to registration) - Absolute neutrophil count (ANC) >= 1,500/mcl (within 14 days prior to registration) - Patients must have creatinine clearance estimated of >= 50 mL/min using the Cockcroft-Gault equation or based on a 24 hour urine test (within 14 days prior to registration) - Total bilirubin level =< 1.5 x institutional upper limit of normal (ULN) or =< 3 x ULN in the presence of documented Gilbert's syndrome (unconjugated hyperbilirubinemia) (within 14 days prior to registration) - Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) =< 3 x ULN (within 14 days prior to registration) - Patients must be able to swallow and retain oral medications and be without gastrointestinal illnesses that would preclude absorption of selumetinib or olaparib - Patients with known history or current symptoms of cardiac disease, or history of treatment with cardiotoxic agents, should have a clinical risk assessment of cardiac function using the New York Heart Association Functional Classification. To be eligible for this trial, patients should be class 2B or better - Women of childbearing potential (WOCBP) must agree to use two forms of birth control (hormonal or barrier method of birth control; abstinence) during the study and for 12 weeks after completing treatment - Non-sterilized male partners of WOCBP (including males sterilized by a method other than bilateral orchidectomy e.g., vasectomy) who intend to be sexually active with a female partner must be using an acceptable method of contraception such as male condom plus spermicide (condom alone in countries where spermicides are not approved) from the time of screening throughout the total duration of the study and the drug washout period (at least 16 weeks after the last dose of study intervention) to prevent pregnancy in a partner. Periodic abstinence, the rhythm method, and the withdrawal method are not acceptable methods of contraception. Vasectomized (i.e., sterile) males are considered fertile and should still use a male condom plus spermicide as indicated above during the clinical study - Patients with a prior or concurrent malignancy whose natural history or treatment does not have the potential to interfere with the safety or efficacy assessment of the investigational regimen are eligible for this trial - Human immunodeficiency virus (HIV)-infected patients on effective anti-retroviral therapy with undetectable viral load within 6 months of registration are eligible for this trial - Patients with evidence of chronic hepatitis B virus (HBV) infection must have an undetectable HBV viral load on suppressive therapy, if indicated - Patients with a history of hepatitis C virus (HCV) infection must have been treated and cured. For patients with HCV infection who are currently on treatment, they are eligible if they have an undetectable HCV viral load - Patients with new or progressive brain metastases (active brain metastases) or leptomeningeal disease are eligible if the treating physician determines that immediate central nervous system (CNS) specific treatment is not required and is unlikely to be required during the first cycle of therapy - Patients with treated brain metastases are eligible if follow-up brain imaging after CNS-directed therapy shows no evidence of progression - Extra caution should be taken with olaparib, as it crosses the blood brain barrier and can cause edema in brain metastases - The patient or a legally authorized representative must provide study-specific informed consent prior to study entry and, for patients treated in the United States (U.S.), authorization permitting release of personal health information Exclusion Criteria: - Patients who have received any MEK inhibitors - Patients who have progressed while receiving a PARP inhibitor - Patients who have received chemotherapy or radiotherapy within 4 weeks (6 weeks for nitrosoureas or mitomycin C) prior to registration - Patients who have not recovered from adverse events due to prior anti-cancer therapy (i.e., have residual toxicities > grade 1) with the exception of alopecia - Patients with uncontrolled intercurrent illness - Patients with >= grade 2 neuropathy within 14 days of registration - Patients with severe (Child-Pugh C) liver dysfunction - Patients with a history of allergic reactions attributed to compounds of similar chemical or biologic composition to olaparib and selumetinib or any excipients thereof - Concomitant use of known strong (e.g., phenobarbital, enzalutamide, phenytoin, rifampicin, rifabutin, rifapentine, carbamazepine, nevirapine and St John's Wort) or moderate CYP3A inducers (e.g., bosentan, efavirenz, modafinil). The required washout period prior to starting olaparib is 5 weeks for enzalutamide or phenobarbital and 3 weeks for other agents - Supplementation with vitamin E greater than 100% of the daily recommended dose. Any multivitamin containing vitamin E must be stopped prior to study enrollment even if less than 100% of the daily recommended dosing for vitamin E - Vitamin E must not be taken in the 7 days prior to initiation of treatment with selumetinib - Concomitant use of known strong CYP3A inhibitors (e.g., itraconazole, telithromycin, clarithromycin, protease inhibitors boosted with ritonavir or cobicistat, indinavir, saquinavir, nelfinavir, boceprevir, telaprevir) or known moderate CYP3A inhibitors (e.g. ciprofloxacin, erythromycin, diltiazem, Fluconazole, verapamil). The required washout period prior to starting olaparib is at least 14 days or 5 half-lives (whichever is longer) before the first dose of study medication - Concomitant use of strong CYP2C19 inhibitors (e.g., ticlopidine) or moderate CYP2C19 inhibitors (e.g., omeprazole). The required washout period prior to starting selumetinib is at least 14 days or 5 half-lives (whichever is longer) before the first dose of study medication - Have received or are receiving an investigational medicinal product (IMP) or other systemic anti-cancer treatment (including chemotherapy, immunotherapy, targeted therapy, biologic therapy, tumor embolization, or monoclonal antibodies) within 4 weeks prior to registration, or within a period during which the IMP or systemic target treatment has not been cleared from the body (e.g., a period of 5 'half-lives'), whichever is longer - Known myelodysplastic syndrome/acute myeloid leukemia or with features suggestive of myelodysplastic syndrome (MDS)/acute myeloid leukemia (AML) - Patients who have had previous organ transplant, allogenic bone marrow transplant or double umbilical cord blood transplantation - Patients who have had whole blood transfusion within 28 days prior to registration - Patients with ophthalmological conditions as follows: - Current or past history of retinal pigment epithelial detachment/central serous retinopathy or retinal vein occlusion. - Intraocular pressure >21 mmHg (or ULN adjusted by age) or uncontrolled glaucoma (irrespective of intraocular pressure [IOP]). Subjects with known glaucoma and increased IOP who do not have meaningful vision (light perception only or no light perception) and are not experiencing pain related to the glaucoma, may be eligible after discussion with the study chair - Patients with any other significant abnormality on ophthalmic examination should be discussed with the study chair for potential eligibility - Ophthalmological findings secondary to long-standing optic pathway glioma (such as visual loss, optic nerve pallor or strabismus) or longstanding orbito-temporal plexiform neurofibroma (PN) (such as visual loss, strabismus) will NOT be considered a significant abnormality for the purposes of the study - Patients with severe, active co-morbidity defined as any of the following: - History and/or confirmed pneumonitis - Uncontrolled hypertension (blood pressure [BP] >= 150/90 mmHg despite medical therapy) - Acute coronary syndrome within 6 months prior to registration - Uncontrolled atrial fibrillation - Known family history of long QT syndrome - Women who are pregnant or unwilling to discontinue nursing

Gender: Female

Minimum age: 18 Years

Maximum age: N/A

Healthy volunteers: No

Locations:

Facility:
Name: University of Alabama at Birmingham Cancer Center

Address:
City: Birmingham
Zip: 35233
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 205-934-0220
Email: tmyrick@uab.edu

Investigator:
Last name: Rebecca C. Arend
Email: Principal Investigator

Facility:
Name: University of South Alabama Mitchell Cancer Institute

Address:
City: Mobile
Zip: 36688
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 251-445-9870
Email: pfrancisco@usouthal.edu

Investigator:
Last name: Nathaniel L. Jones
Email: Principal Investigator

Facility:
Name: CTCA at Western Regional Medical Center

Address:
City: Goodyear
Zip: 85338
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 623-207-3000

Investigator:
Last name: Sagun Shrestha
Email: Principal Investigator

Facility:
Name: Kingman Regional Medical Center

Address:
City: Kingman
Zip: 86401
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 702-384-0013
Email: research@sncrf.org

Investigator:
Last name: John A. Ellerton
Email: Principal Investigator

Facility:
Name: PCR Oncology

Address:
City: Arroyo Grande
Zip: 93420
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 702-384-0013
Email: research@sncrf.org

Investigator:
Last name: John A. Ellerton
Email: Principal Investigator

Facility:
Name: Saint Joseph Hospital - Orange

Address:
City: Orange
Zip: 92868
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 714-734-6220

Investigator:
Last name: Timothy E. Byun
Email: Principal Investigator

Facility:
Name: Presbyterian Intercommunity Hospital

Address:
City: Whittier
Zip: 90602
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 562-698-0811

Investigator:
Last name: Christopher R. Foss
Email: Principal Investigator

Facility:
Name: UM Sylvester Comprehensive Cancer Center at Aventura

Address:
City: Aventura
Zip: 33180
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 954-461-2180

Investigator:
Last name: Chukwuemeka (Emeka) V. Ikpeazu
Email: Principal Investigator

Facility:
Name: UM Sylvester Comprehensive Cancer Center at Coral Gables

Address:
City: Coral Gables
Zip: 33146
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 305-243-2647

Investigator:
Last name: Chukwuemeka (Emeka) V. Ikpeazu
Email: Principal Investigator

Facility:
Name: UM Sylvester Comprehensive Cancer Center at Deerfield Beach

Address:
City: Deerfield Beach
Zip: 33442
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 305-243-2647

Investigator:
Last name: Chukwuemeka (Emeka) V. Ikpeazu
Email: Principal Investigator

Facility:
Name: Mayo Clinic in Florida

Address:
City: Jacksonville
Zip: 32224-9980
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 855-776-0015

Investigator:
Last name: Grace M. Choong
Email: Principal Investigator

Facility:
Name: University of Miami Miller School of Medicine-Sylvester Cancer Center

Address:
City: Miami
Zip: 33136
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 305-243-2647

Investigator:
Last name: Chukwuemeka (Emeka) V. Ikpeazu
Email: Principal Investigator

Facility:
Name: UM Sylvester Comprehensive Cancer Center at Kendall

Address:
City: Miami
Zip: 33176
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 305-243-2647

Investigator:
Last name: Chukwuemeka (Emeka) V. Ikpeazu
Email: Principal Investigator

Facility:
Name: UM Sylvester Comprehensive Cancer Center at Plantation

Address:
City: Plantation
Zip: 33324
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 305-243-2647

Investigator:
Last name: Chukwuemeka (Emeka) V. Ikpeazu
Email: Principal Investigator

Facility:
Name: The Queen's Medical Center - West Oahu

Address:
City: 'Ewa Beach
Zip: 96706
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact
Email: rohta@queens.org

Investigator:
Last name: Michael E. Carney
Email: Principal Investigator

Facility:
Name: Queen's Cancer Cenrer - POB I

Address:
City: Honolulu
Zip: 96813
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 808-532-0315

Investigator:
Last name: Michael E. Carney
Email: Principal Investigator

Facility:
Name: Queen's Medical Center

Address:
City: Honolulu
Zip: 96813
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 808-545-8548

Investigator:
Last name: Michael E. Carney
Email: Principal Investigator

Facility:
Name: Queen's Cancer Center - Kuakini

Address:
City: Honolulu
Zip: 96817
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 808-531-8521

Investigator:
Last name: Michael E. Carney
Email: Principal Investigator

Facility:
Name: Kapiolani Medical Center for Women and Children

Address:
City: Honolulu
Zip: 96826
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 808-983-6090

Investigator:
Last name: Michael E. Carney
Email: Principal Investigator

Facility:
Name: Saint Alphonsus Cancer Care Center-Boise

Address:
City: Boise
Zip: 83706
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 734-712-3671
Email: stephanie.couch@stjoeshealth.org

Investigator:
Last name: John M. Schallenkamp
Email: Principal Investigator

Facility:
Name: Saint Luke's Cancer Institute - Boise

Address:
City: Boise
Zip: 83712
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 208-381-2774
Email: eslinget@slhs.org

Investigator:
Last name: Dan S. Zuckerman
Email: Principal Investigator

Facility:
Name: Saint Alphonsus Cancer Care Center-Caldwell

Address:
City: Caldwell
Zip: 83605
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 734-712-3671
Email: stephanie.couch@stjoeshealth.org

Investigator:
Last name: John M. Schallenkamp
Email: Principal Investigator

Facility:
Name: Kootenai Health - Coeur d'Alene

Address:
City: Coeur d'Alene
Zip: 83814
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 406-969-6060
Email: mccinfo@mtcancer.org

Investigator:
Last name: John M. Schallenkamp
Email: Principal Investigator

Facility:
Name: Saint Luke's Cancer Institute - Fruitland

Address:
City: Fruitland
Zip: 83619
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 208-381-2774
Email: eslinget@slhs.org

Investigator:
Last name: Dan S. Zuckerman
Email: Principal Investigator

Facility:
Name: Saint Luke's Cancer Institute - Meridian

Address:
City: Meridian
Zip: 83642
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 208-381-2774
Email: eslinget@slhs.org

Investigator:
Last name: Dan S. Zuckerman
Email: Principal Investigator

Facility:
Name: Saint Alphonsus Cancer Care Center-Nampa

Address:
City: Nampa
Zip: 83687
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 406-969-6060
Email: mccinfo@mtcancer.org

Investigator:
Last name: John M. Schallenkamp
Email: Principal Investigator

Facility:
Name: Saint Luke's Cancer Institute - Nampa

Address:
City: Nampa
Zip: 83687
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 208-381-2774
Email: eslinget@slhs.org

Investigator:
Last name: Dan S. Zuckerman
Email: Principal Investigator

Facility:
Name: Kootenai Clinic Cancer Services - Post Falls

Address:
City: Post Falls
Zip: 83854
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 406-969-6060
Email: mccinfo@mtcancer.org

Investigator:
Last name: John M. Schallenkamp
Email: Principal Investigator

Facility:
Name: Kootenai Clinic Cancer Services - Sandpoint

Address:
City: Sandpoint
Zip: 83864
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 406-969-6060
Email: mccinfo@mtcancer.org

Investigator:
Last name: John M. Schallenkamp
Email: Principal Investigator

Facility:
Name: Saint Luke's Cancer Institute - Twin Falls

Address:
City: Twin Falls
Zip: 83301
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 208-381-2774
Email: eslinget@slhs.org

Investigator:
Last name: Dan S. Zuckerman
Email: Principal Investigator

Facility:
Name: Advocate Good Shepherd Hospital

Address:
City: Barrington
Zip: 60010
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 847-842-4847

Investigator:
Last name: Antony Ruggeri
Email: Principal Investigator

Facility:
Name: Illinois CancerCare-Bloomington

Address:
City: Bloomington
Zip: 61704
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 309-243-3605
Email: andersonj@illinoiscancercare.com

Investigator:
Last name: Bryan A. Faller
Email: Principal Investigator

Facility:
Name: Illinois CancerCare-Canton

Address:
City: Canton
Zip: 61520
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 309-243-3605
Email: andersonj@illinoiscancercare.com

Investigator:
Last name: Bryan A. Faller
Email: Principal Investigator

Facility:
Name: Illinois CancerCare-Carthage

Address:
City: Carthage
Zip: 62321
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 309-243-3605
Email: andersonj@illinoiscancercare.com

Investigator:
Last name: Bryan A. Faller
Email: Principal Investigator

Facility:
Name: Centralia Oncology Clinic

Address:
City: Centralia
Zip: 62801
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 217-876-4762
Email: morganthaler.jodi@mhsil.com

Investigator:
Last name: Bryan A. Faller
Email: Principal Investigator

Facility:
Name: John H Stroger Jr Hospital of Cook County

Address:
City: Chicago
Zip: 60612
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 312-864-5204

Investigator:
Last name: Thomas E. Lad
Email: Principal Investigator

Facility:
Name: University of Chicago Comprehensive Cancer Center

Address:
City: Chicago
Zip: 60637
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 773-702-8222
Email: cancerclinicaltrials@bsd.uchicago.edu

Investigator:
Last name: Katherine C. Kurnit
Email: Principal Investigator

Facility:
Name: Advocate Illinois Masonic Medical Center

Address:
City: Chicago
Zip: 60657
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 773-296-5360

Investigator:
Last name: Antony Ruggeri
Email: Principal Investigator

Facility:
Name: AMG Crystal Lake - Oncology

Address:
City: Crystal Lake
Zip: 60014
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 630-929-6129
Email: advocateresearch@advocate.com

Investigator:
Last name: Antony Ruggeri
Email: Principal Investigator

Facility:
Name: Carle at The Riverfront

Address:
City: Danville
Zip: 61832
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 800-446-5532
Email: Research@Carle.com

Investigator:
Last name: Georgina Cheng
Email: Principal Investigator

Facility:
Name: Cancer Care Specialists of Illinois - Decatur

Address:
City: Decatur
Zip: 62526
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 217-876-4762
Email: morganthaler.jodi@mhsil.com

Investigator:
Last name: Bryan A. Faller
Email: Principal Investigator

Facility:
Name: Decatur Memorial Hospital

Address:
City: Decatur
Zip: 62526
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 217-876-4762
Email: morganthaler.jodi@mhsil.com

Investigator:
Last name: Bryan A. Faller
Email: Principal Investigator

Facility:
Name: Illinois CancerCare-Dixon

Address:
City: Dixon
Zip: 61021
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 815-285-7800

Investigator:
Last name: Bryan A. Faller
Email: Principal Investigator

Facility:
Name: Advocate Good Samaritan Hospital

Address:
City: Downers Grove
Zip: 60515
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 630-275-1270
Email: Barbara.barhamand@advocatehealth.com

Investigator:
Last name: Antony Ruggeri
Email: Principal Investigator

Facility:
Name: Carle Physician Group-Effingham

Address:
City: Effingham
Zip: 62401
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 800-446-5532
Email: Research@carle.com

Investigator:
Last name: Georgina Cheng
Email: Principal Investigator

Facility:
Name: Crossroads Cancer Center

Address:
City: Effingham
Zip: 62401
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 217-876-4762
Email: morganthaler.jodi@mhsil.com

Investigator:
Last name: Bryan A. Faller
Email: Principal Investigator

Facility:
Name: Advocate Sherman Hospital

Address:
City: Elgin
Zip: 60123
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 847-429-2907

Investigator:
Last name: Antony Ruggeri
Email: Principal Investigator

Facility:
Name: Illinois CancerCare-Eureka

Address:
City: Eureka
Zip: 61530
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 309-243-3605
Email: andersonj@illinoiscancercare.com

Investigator:
Last name: Bryan A. Faller
Email: Principal Investigator

Facility:
Name: Illinois CancerCare-Galesburg

Address:
City: Galesburg
Zip: 61401
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 309-243-3605
Email: andersonj@illinoiscancercare.com

Investigator:
Last name: Bryan A. Faller
Email: Principal Investigator

Facility:
Name: Advocate South Suburban Hospital

Address:
City: Hazel Crest
Zip: 60429
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 708-799-9995

Investigator:
Last name: Antony Ruggeri
Email: Principal Investigator

Facility:
Name: Illinois CancerCare-Kewanee Clinic

Address:
City: Kewanee
Zip: 61443
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 309-243-3605
Email: andersonj@illinoiscancercare.com

Investigator:
Last name: Bryan A. Faller
Email: Principal Investigator

Facility:
Name: AMG Libertyville - Oncology

Address:
City: Libertyville
Zip: 60048
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 630-929-6129
Email: advocateresearch@advocatehealth.com

Investigator:
Last name: Antony Ruggeri
Email: Principal Investigator

Facility:
Name: Condell Memorial Hospital

Address:
City: Libertyville
Zip: 60048
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 630-929-6129
Email: advocateresearch@advocatehealth.com

Investigator:
Last name: Antony Ruggeri
Email: Principal Investigator

Facility:
Name: Illinois CancerCare-Macomb

Address:
City: Macomb
Zip: 61455
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 309-243-3605
Email: andersonj@illinoiscancercare.com

Investigator:
Last name: Bryan A. Faller
Email: Principal Investigator

Facility:
Name: Carle Physician Group-Mattoon/Charleston

Address:
City: Mattoon
Zip: 61938
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 800-446-5532
Email: Research@carle.com

Investigator:
Last name: Georgina Cheng
Email: Principal Investigator

Facility:
Name: UC Comprehensive Cancer Center at Silver Cross

Address:
City: New Lenox
Zip: 60451
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 773-702-8222
Email: cancerclinicaltrials@bsd.uchicago.edu

Investigator:
Last name: Katherine C. Kurnit
Email: Principal Investigator

Facility:
Name: Cancer Care Center of O'Fallon

Address:
City: O'Fallon
Zip: 62269
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 217-876-4762
Email: morganthaler.jodi@mhsil.com

Investigator:
Last name: Bryan A. Faller
Email: Principal Investigator

Facility:
Name: Advocate Christ Medical Center

Address:
City: Oak Lawn
Zip: 60453-2699
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 800-323-8622

Investigator:
Last name: Antony Ruggeri
Email: Principal Investigator

Facility:
Name: University of Chicago Medicine-Orland Park

Address:
City: Orland Park
Zip: 60462
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 773-702-8222
Email: cancerclinicaltrials@bsd.uchicago.edu

Investigator:
Last name: Katherine C. Kurnit
Email: Principal Investigator

Facility:
Name: Illinois CancerCare-Ottawa Clinic

Address:
City: Ottawa
Zip: 61350
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 309-243-3605
Email: andersonj@illinoiscancercare.com

Investigator:
Last name: Bryan A. Faller
Email: Principal Investigator

Facility:
Name: Advocate Lutheran General Hospital

Address:
City: Park Ridge
Zip: 60068
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 847-384-3621

Investigator:
Last name: Antony Ruggeri
Email: Principal Investigator

Facility:
Name: Illinois CancerCare-Pekin

Address:
City: Pekin
Zip: 61554
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 309-243-3605
Email: andersonj@illinoiscancercare.com

Investigator:
Last name: Bryan A. Faller
Email: Principal Investigator

Facility:
Name: Illinois CancerCare-Peoria

Address:
City: Peoria
Zip: 61615
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 309-243-3605
Email: andersonj@illinoiscancercare.com

Investigator:
Last name: Bryan A. Faller
Email: Principal Investigator

Facility:
Name: Illinois CancerCare-Peru

Address:
City: Peru
Zip: 61354
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 309-243-3605
Email: andersonj@illinoiscancercare.com

Investigator:
Last name: Bryan A. Faller
Email: Principal Investigator

Facility:
Name: Illinois CancerCare-Princeton

Address:
City: Princeton
Zip: 61356
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 309-243-3605
Email: andersonj@illinoiscancercare.com

Investigator:
Last name: Bryan A. Faller
Email: Principal Investigator

Facility:
Name: Southern Illinois University School of Medicine

Address:
City: Springfield
Zip: 62702
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 217-545-7929

Investigator:
Last name: Bryan A. Faller
Email: Principal Investigator

Facility:
Name: Springfield Clinic

Address:
City: Springfield
Zip: 62702
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 800-444-7541

Investigator:
Last name: Bryan A. Faller
Email: Principal Investigator

Facility:
Name: Springfield Memorial Hospital

Address:
City: Springfield
Zip: 62781
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 217-528-7541
Email: pallante.beth@mhsil.com

Investigator:
Last name: Bryan A. Faller
Email: Principal Investigator

Facility:
Name: Carle Cancer Center

Address:
City: Urbana
Zip: 61801
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 800-446-5532
Email: Research@carle.com

Investigator:
Last name: Georgina Cheng
Email: Principal Investigator

Facility:
Name: Illinois CancerCare - Washington

Address:
City: Washington
Zip: 61571
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 309-243-3605
Email: andersonj@illinoiscancercare.com

Investigator:
Last name: Bryan A. Faller
Email: Principal Investigator

Facility:
Name: Mission Cancer and Blood - Ankeny

Address:
City: Ankeny
Zip: 50023
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 515-282-2921

Investigator:
Last name: Seema Harichand-Herdt
Email: Principal Investigator

Facility:
Name: Mission Cancer and Blood - Des Moines

Address:
City: Des Moines
Zip: 50309
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 515-241-3305

Investigator:
Last name: Seema Harichand-Herdt
Email: Principal Investigator

Facility:
Name: Mercy Medical Center - Des Moines

Address:
City: Des Moines
Zip: 50314
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 515-358-6613
Email: cancerresearch@mercydesmoines.org

Investigator:
Last name: Richard L. Deming
Email: Principal Investigator

Facility:
Name: University of Kentucky/Markey Cancer Center

Address:
City: Lexington
Zip: 40536
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 859-257-3379

Investigator:
Last name: Susanne M. Arnold
Email: Principal Investigator

Facility:
Name: Ochsner Baptist Medical Center

Address:
City: New Orleans
Zip: 70115
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 504-842-8084
Email: Elisemarie.curry@ochsner.org

Investigator:
Last name: Katrina S. Wade
Email: Principal Investigator

Facility:
Name: Ochsner Medical Center Jefferson

Address:
City: New Orleans
Zip: 70121
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 504-842-8084
Email: Elisemarie.curry@ochsner.org

Investigator:
Last name: Katrina S. Wade
Email: Principal Investigator

Facility:
Name: Lafayette Family Cancer Center-EMMC

Address:
City: Brewer
Zip: 04412
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 800-987-3005

Investigator:
Last name: Sarah J. Sinclair
Email: Principal Investigator

Facility:
Name: Maine Medical Center- Scarborough Campus

Address:
City: Scarborough
Zip: 04074
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 207-396-8090
Email: wrighd@mmc.org

Investigator:
Last name: Leslie S. Bradford
Email: Principal Investigator

Facility:
Name: University of Maryland/Greenebaum Cancer Center

Address:
City: Baltimore
Zip: 21201
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 800-888-8823

Investigator:
Last name: Ranee Mehra
Email: Principal Investigator

Facility:
Name: Walter Reed National Military Medical Center

Address:
City: Bethesda
Zip: 20889-5600
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 301-319-2100

Investigator:
Last name: Christopher Tarney
Email: Principal Investigator

Facility:
Name: National Institutes of Health Clinical Center

Address:
City: Bethesda
Zip: 20892
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 800-411-1222

Investigator:
Last name: A P. Chen
Email: Principal Investigator

Facility:
Name: UPMC Western Maryland

Address:
City: Cumberland
Zip: 21502
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 240-964-1400

Investigator:
Last name: Alexander B. Olawaiye
Email: Principal Investigator

Facility:
Name: Tufts Medical Center

Address:
City: Boston
Zip: 02111
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 617-636-5000
Email: ContactUsCancerCenter@TuftsMedicalCenter.org

Investigator:
Last name: Sarah E. Paraghamian
Email: Principal Investigator

Facility:
Name: Baystate Medical Center

Address:
City: Springfield
Zip: 01199
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 413-794-3565
Email: tamara.wrenn@baystatehealth.org

Investigator:
Last name: Tashanna K. Myers
Email: Principal Investigator

Facility:
Name: Trinity Health Saint Joseph Mercy Hospital Ann Arbor

Address:
City: Ann Arbor
Zip: 48106
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 734-712-7251
Email: MCRCwebsitecontactform@stjoeshealth.org

Investigator:
Last name: Tareq Al baghdadi
Email: Principal Investigator

Facility:
Name: University of Michigan Comprehensive Cancer Center

Address:
City: Ann Arbor
Zip: 48109
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 800-865-1125

Investigator:
Last name: Jean H. Siedel
Email: Principal Investigator

Facility:
Name: Trinity Health IHA Medical Group Hematology Oncology - Brighton

Address:
City: Brighton
Zip: 48114
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 734-712-7251
Email: MCRCwebsitecontactform@stjoeshealth.org

Investigator:
Last name: Tareq Al baghdadi
Email: Principal Investigator

Facility:
Name: Trinity Health Medical Center - Brighton

Address:
City: Brighton
Zip: 48114
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 734-712-7251
Email: MCRCwebsitecontactform@stjoeshealth.org

Investigator:
Last name: Tareq Al baghdadi
Email: Principal Investigator

Facility:
Name: University of Michigan - Brighton Center for Specialty Care

Address:
City: Brighton
Zip: 48116
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 800-865-1125

Investigator:
Last name: Jean H. Siedel
Email: Principal Investigator

Facility:
Name: Trinity Health IHA Medical Group Hematology Oncology - Canton

Address:
City: Canton
Zip: 48188
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 734-712-7251
Email: MCRCwebsitecontactform@stjoeshealth.org

Investigator:
Last name: Tareq Al baghdadi
Email: Principal Investigator

Facility:
Name: Trinity Health Medical Center - Canton

Address:
City: Canton
Zip: 48188
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 734-712-7251
Email: MCRCwebsitecontactform@stjoeshealth.org

Investigator:
Last name: Tareq Al baghdadi
Email: Principal Investigator

Facility:
Name: Chelsea Hospital

Address:
City: Chelsea
Zip: 48118
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 734-712-7251
Email: MCRCwebsitecontactform@stjoeshealth.org

Investigator:
Last name: Tareq Al baghdadi
Email: Principal Investigator

Facility:
Name: Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital

Address:
City: Chelsea
Zip: 48118
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 734-712-7251
Email: MCRCwebsitecontactform@stjoeshealth.org

Investigator:
Last name: Tareq Al baghdadi
Email: Principal Investigator

Facility:
Name: Corewell Health Dearborn Hospital

Address:
City: Dearborn
Zip: 48124
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 248-551-7695

Investigator:
Last name: Dana Zakalik
Email: Principal Investigator

Facility:
Name: Corewell Health Farmington Hills Hospital

Address:
City: Farmington Hills
Zip: 48336
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 248-551-7695

Investigator:
Last name: Dana Zakalik
Email: Principal Investigator

Facility:
Name: Genesee Cancer and Blood Disease Treatment Center

Address:
City: Flint
Zip: 48503
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 810-762-8038
Email: wstrong@ghci.org

Investigator:
Last name: Tareq Al baghdadi
Email: Principal Investigator

Facility:
Name: Genesee Hematology Oncology PC

Address:
City: Flint
Zip: 48503
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 810-762-8038
Email: wstrong@ghci.org

Investigator:
Last name: Tareq Al baghdadi
Email: Principal Investigator

Facility:
Name: Genesys Hurley Cancer Institute

Address:
City: Flint
Zip: 48503
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 810-762-8038
Email: wstrong@ghci.org

Investigator:
Last name: Tareq Al baghdadi
Email: Principal Investigator

Facility:
Name: Hurley Medical Center

Address:
City: Flint
Zip: 48503
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 810-762-8038
Email: wstrong@ghci.org

Investigator:
Last name: Tareq Al baghdadi
Email: Principal Investigator

Facility:
Name: University of Michigan Health - Sparrow Lansing

Address:
City: Lansing
Zip: 48912
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 517-364-3712
Email: harsha.trivedi@umhsparrow.org

Investigator:
Last name: Tareq Al baghdadi
Email: Principal Investigator

Facility:
Name: Trinity Health Saint Mary Mercy Livonia Hospital

Address:
City: Livonia
Zip: 48154
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 734-712-7251
Email: MCRCwebsitecontactform@stjoeshealth.org

Investigator:
Last name: Tareq Al baghdadi
Email: Principal Investigator

Facility:
Name: Henry Ford Saint John Hospital - Macomb Medical

Address:
City: Macomb
Zip: 48044
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 313-343-3166
Email: kforman1@hfhs.org

Investigator:
Last name: Tareq Al baghdadi
Email: Principal Investigator

Facility:
Name: Corewell Health William Beaumont University Hospital

Address:
City: Royal Oak
Zip: 48073
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 248-551-7695

Investigator:
Last name: Dana Zakalik
Email: Principal Investigator

Facility:
Name: Corewell Health Beaumont Troy Hospital

Address:
City: Troy
Zip: 48085
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 248-551-7695

Investigator:
Last name: Dana Zakalik
Email: Principal Investigator

Facility:
Name: Huron Gastroenterology PC

Address:
City: Ypsilanti
Zip: 48106
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 734-712-7251
Email: MCRCwebsitecontactform@stjoeshealth.org

Investigator:
Last name: Tareq Al baghdadi
Email: Principal Investigator

Facility:
Name: Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus

Address:
City: Ypsilanti
Zip: 48197
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 734-712-7251
Email: MCRCwebsitecontactform@stjoeshealth.org

Investigator:
Last name: Tareq Al baghdadi
Email: Principal Investigator

Facility:
Name: Mercy Hospital

Address:
City: Coon Rapids
Zip: 55433
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 952-993-1517
Email: mmcorc@healthpartners.com

Investigator:
Last name: Yan Ji
Email: Principal Investigator

Facility:
Name: Essentia Health - Deer River Clinic

Address:
City: Deer River
Zip: 56636
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 218-786-3308
Email: CancerTrials@EssentiaHealth.org

Investigator:
Last name: Bret E. Friday
Email: Principal Investigator

Facility:
Name: Essentia Health Cancer Center

Address:
City: Duluth
Zip: 55805
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 218-786-3308
Email: CancerTrials@EssentiaHealth.org

Investigator:
Last name: Bret E. Friday
Email: Principal Investigator

Facility:
Name: Fairview Southdale Hospital

Address:
City: Edina
Zip: 55435
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 952-993-1517
Email: mmcorc@healthpartners.com

Investigator:
Last name: Yan Ji
Email: Principal Investigator

Facility:
Name: Essentia Health Hibbing Clinic

Address:
City: Hibbing
Zip: 55746
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 218-786-3308

Investigator:
Last name: Bret E. Friday
Email: Principal Investigator

Facility:
Name: Fairview Clinics and Surgery Center Maple Grove

Address:
City: Maple Grove
Zip: 55369
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 952-993-1517
Email: mmcorc@healthpartners.com

Investigator:
Last name: Yan Ji
Email: Principal Investigator

Facility:
Name: Abbott-Northwestern Hospital

Address:
City: Minneapolis
Zip: 55407
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 952-993-1517
Email: mmcorc@healthpartners.com

Investigator:
Last name: Yan Ji
Email: Principal Investigator

Facility:
Name: Mayo Clinic in Rochester

Address:
City: Rochester
Zip: 55905
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 855-776-0015

Investigator:
Last name: Grace M. Choong
Email: Principal Investigator

Facility:
Name: Park Nicollet Clinic - Saint Louis Park

Address:
City: Saint Louis Park
Zip: 55416
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 952-993-1517
Email: mmcorc@healthpartners.com

Investigator:
Last name: Yan Ji
Email: Principal Investigator

Facility:
Name: Regions Hospital

Address:
City: Saint Paul
Zip: 55101
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 952-993-1517
Email: mmcorc@healthpartners.com

Investigator:
Last name: Yan Ji
Email: Principal Investigator

Facility:
Name: United Hospital

Address:
City: Saint Paul
Zip: 55102
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 952-993-1517
Email: mmcorc@healthpartners.com

Investigator:
Last name: Yan Ji
Email: Principal Investigator

Facility:
Name: Essentia Health Sandstone

Address:
City: Sandstone
Zip: 55072
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 218-786-3308
Email: CancerTrials@EssentiaHealth.org

Investigator:
Last name: Bret E. Friday
Email: Principal Investigator

Facility:
Name: Essentia Health Virginia Clinic

Address:
City: Virginia
Zip: 55792
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 218-786-3308
Email: CancerTrials@EssentiaHealth.org

Investigator:
Last name: Bret E. Friday
Email: Principal Investigator

Facility:
Name: Saint Francis Medical Center

Address:
City: Cape Girardeau
Zip: 63703
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 573-334-2230
Email: sfmc@sfmc.net

Investigator:
Last name: Bryan A. Faller
Email: Principal Investigator

Facility:
Name: Washington University School of Medicine

Address:
City: Saint Louis
Zip: 63110
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 800-600-3606
Email: info@siteman.wustl.edu

Investigator:
Last name: Premal H. Thaker
Email: Principal Investigator

Facility:
Name: Community Hospital of Anaconda

Address:
City: Anaconda
Zip: 59711
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 406-969-6060
Email: mccinfo@mtcancer.org

Investigator:
Last name: John M. Schallenkamp
Email: Principal Investigator

Facility:
Name: Billings Clinic Cancer Center

Address:
City: Billings
Zip: 59101
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 800-996-2663
Email: research@billingsclinic.org

Investigator:
Last name: John M. Schallenkamp
Email: Principal Investigator

Facility:
Name: Bozeman Health Deaconess Hospital

Address:
City: Bozeman
Zip: 59715
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 406-969-6060
Email: mccinfo@mtcancer.org

Investigator:
Last name: John M. Schallenkamp
Email: Principal Investigator

Facility:
Name: Benefis Sletten Cancer Institute

Address:
City: Great Falls
Zip: 59405
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 406-969-6060
Email: mccinfo@mtcancer.org

Investigator:
Last name: John M. Schallenkamp
Email: Principal Investigator

Facility:
Name: Logan Health Medical Center

Address:
City: Kalispell
Zip: 59901
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 406-969-6060
Email: mccinfo@mtcancer.org

Investigator:
Last name: John M. Schallenkamp
Email: Principal Investigator

Facility:
Name: Community Medical Center

Address:
City: Missoula
Zip: 59804
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 406-969-6060
Email: mccinfo@mtcancer.org

Investigator:
Last name: John M. Schallenkamp
Email: Principal Investigator

Facility:
Name: OptumCare Cancer Care at Seven Hills

Address:
City: Henderson
Zip: 89052
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 702-384-0013
Email: research@sncrf.org

Investigator:
Last name: John A. Ellerton
Email: Principal Investigator

Facility:
Name: OptumCare Cancer Care at Charleston

Address:
City: Las Vegas
Zip: 89102
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 702-384-0013
Email: research@sncrf.org

Investigator:
Last name: John A. Ellerton
Email: Principal Investigator

Facility:
Name: OptumCare Cancer Care at Fort Apache

Address:
City: Las Vegas
Zip: 89148
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 702-384-0013
Email: research@sncrf.org

Investigator:
Last name: John A. Ellerton
Email: Principal Investigator

Facility:
Name: Jersey City Medical Center

Address:
City: Jersey City
Zip: 07302
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 412-339-5294
Email: Roster@nrgoncology.org

Investigator:
Last name: Aliza L. Leiser
Email: Principal Investigator

Facility:
Name: Monmouth Medical Center Southern Campus

Address:
City: Lakewood
Zip: 08701
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 732-923-6564
Email: mary.danish@rwjbh.org

Investigator:
Last name: Aliza L. Leiser
Email: Principal Investigator

Facility:
Name: Monmouth Medical Center

Address:
City: Long Branch
Zip: 07740
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 732-923-6564
Email: mary.danish@rwjbh.org

Investigator:
Last name: Aliza L. Leiser
Email: Principal Investigator

Facility:
Name: Memorial Sloan Kettering Monmouth

Address:
City: Middletown
Zip: 07748
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 212-639-7592

Investigator:
Last name: Claire F. Friedman
Email: Principal Investigator

Facility:
Name: Rutgers Cancer Institute of New Jersey

Address:
City: New Brunswick
Zip: 08903
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 732-235-7356

Investigator:
Last name: Aliza L. Leiser
Email: Principal Investigator

Facility:
Name: Sidney Kimmel Cancer Center Washington Township

Address:
City: Sewell
Zip: 08080
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 215-600-9151
Email: ONCTrialNow@jefferson.edu

Investigator:
Last name: Mitchell I. Edelson
Email: Principal Investigator

Facility:
Name: University of New Mexico Cancer Center

Address:
City: Albuquerque
Zip: 87106
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 505-925-0348
Email: HSC-ClinicalTrialInfo@salud.unm.edu

Investigator:
Last name: Carolyn Y. Muller
Email: Principal Investigator

Facility:
Name: Roswell Park Cancer Institute

Address:
City: Buffalo
Zip: 14263
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 800-767-9355
Email: askroswell@roswellpark.org

Investigator:
Last name: Ellis G. Levine
Email: Principal Investigator

Facility:
Name: Memorial Sloan Kettering Commack

Address:
City: Commack
Zip: 11725
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 212-639-7592

Investigator:
Last name: Claire F. Friedman
Email: Principal Investigator

Facility:
Name: Memorial Sloan Kettering Westchester

Address:
City: Harrison
Zip: 10604
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 212-639-7592

Investigator:
Last name: Claire F. Friedman
Email: Principal Investigator

Facility:
Name: Memorial Sloan Kettering Cancer Center

Address:
City: New York
Zip: 10065
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 212-639-7592

Investigator:
Last name: Claire F. Friedman
Email: Principal Investigator

Facility:
Name: State University of New York Upstate Medical University

Address:
City: Syracuse
Zip: 13210
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 315-464-5476

Investigator:
Last name: Mary J. Cunningham
Email: Principal Investigator

Facility:
Name: Duke University Medical Center

Address:
City: Durham
Zip: 27710
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 888-275-3853

Investigator:
Last name: Angeles A. Secord
Email: Principal Investigator

Facility:
Name: Duke Women's Cancer Care Raleigh

Address:
City: Raleigh
Zip: 27607
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 919-785-4878

Investigator:
Last name: Angeles A. Secord
Email: Principal Investigator

Facility:
Name: Sanford Broadway Medical Center

Address:
City: Fargo
Zip: 58122
Country: United States

Status: Suspended

Facility:
Name: Sanford Roger Maris Cancer Center

Address:
City: Fargo
Zip: 58122
Country: United States

Status: Suspended

Facility:
Name: UH Seidman Cancer Center at UH Avon Health Center

Address:
City: Avon
Zip: 44011
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 800-641-2422

Investigator:
Last name: Alberto J. Montero
Email: Principal Investigator

Facility:
Name: UHHS-Chagrin Highlands Medical Center

Address:
City: Beachwood
Zip: 44122
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 800-641-2422
Email: CTUReferral@UHhospitals.org

Investigator:
Last name: Alberto J. Montero
Email: Principal Investigator

Facility:
Name: Strecker Cancer Center-Belpre

Address:
City: Belpre
Zip: 45714
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 614-488-2745
Email: Jeffh@columbusccop.org

Investigator:
Last name: William A. Wilson
Email: Principal Investigator

Facility:
Name: Aultman Health Foundation

Address:
City: Canton
Zip: 44710
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 330-363-7274
Email: ClinicalReserachDept@aultman.com

Investigator:
Last name: Sunitha Vemulapalli
Email: Principal Investigator

Facility:
Name: Miami Valley Hospital South

Address:
City: Centerville
Zip: 45459
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 937-528-2900
Email: clinical.trials@daytonncorp.org

Investigator:
Last name: Michael S. Guy
Email: Principal Investigator

Facility:
Name: Adena Regional Medical Center

Address:
City: Chillicothe
Zip: 45601
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 877-779-7585
Email: Jeffh@columbusccop.org

Investigator:
Last name: William A. Wilson
Email: Principal Investigator

Facility:
Name: Case Western Reserve University

Address:
City: Cleveland
Zip: 44106
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 800-641-2422
Email: CTUReferral@UHhospitals.org

Investigator:
Last name: Alberto J. Montero
Email: Principal Investigator

Facility:
Name: Ohio State University Comprehensive Cancer Center

Address:
City: Columbus
Zip: 43210
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 800-293-5066
Email: Jamesline@osumc.edu

Investigator:
Last name: Floor Backes
Email: Principal Investigator

Facility:
Name: Mount Carmel East Hospital

Address:
City: Columbus
Zip: 43213
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 614-488-2745
Email: Jeffh@columbusccop.org

Investigator:
Last name: William A. Wilson
Email: Principal Investigator

Facility:
Name: Riverside Methodist Hospital

Address:
City: Columbus
Zip: 43214
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 614-788-3860
Email: Jennifer.Sexton@ohiohealth.com

Investigator:
Last name: Aine E. Clements
Email: Principal Investigator

Facility:
Name: The Mark H Zangmeister Center

Address:
City: Columbus
Zip: 43219
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 614-488-2745
Email: Jeffh@columbusccop.org

Investigator:
Last name: William A. Wilson
Email: Principal Investigator

Facility:
Name: Miami Valley Hospital

Address:
City: Dayton
Zip: 45409
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 937-528-2900
Email: clinical.trials@daytonncorp.org

Investigator:
Last name: Michael S. Guy
Email: Principal Investigator

Facility:
Name: Dayton Physician LLC - Englewood

Address:
City: Dayton
Zip: 45415
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 937-528-2900
Email: clinical.trials@daytonncorp.org

Investigator:
Last name: Howard M. Gross
Email: Principal Investigator

Facility:
Name: Miami Valley Hospital North

Address:
City: Dayton
Zip: 45415
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 937-528-2900
Email: clinical.trials@daytonncorp.org

Investigator:
Last name: Michael S. Guy
Email: Principal Investigator

Facility:
Name: Atrium Medical Center-Middletown Regional Hospital

Address:
City: Franklin
Zip: 45005-1066
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 937-528-2900
Email: clinical.trials@daytonncorp.org

Investigator:
Last name: Michael S. Guy
Email: Principal Investigator

Facility:
Name: Miami Valley Cancer Care and Infusion

Address:
City: Greenville
Zip: 45331
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 937-569-7515

Investigator:
Last name: Michael S. Guy
Email: Principal Investigator

Facility:
Name: Kettering Medical Center

Address:
City: Kettering
Zip: 45429
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 937-528-2900
Email: clinical.trials@daytonncorp.org

Investigator:
Last name: Howard M. Gross
Email: Principal Investigator

Facility:
Name: Fairfield Medical Center

Address:
City: Lancaster
Zip: 43130
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 614-488-2745
Email: Jeffh@columbusccop.org

Investigator:
Last name: William A. Wilson
Email: Principal Investigator

Facility:
Name: Marietta Memorial Hospital

Address:
City: Marietta
Zip: 45750
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 614-488-2745
Email: Jeffh@columbusccop.org

Investigator:
Last name: William A. Wilson
Email: Principal Investigator

Facility:
Name: Memorial Hospital

Address:
City: Marysville
Zip: 43040
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 614-488-2745
Email: Jeffh@columbusccop.org

Investigator:
Last name: William A. Wilson
Email: Principal Investigator

Facility:
Name: UH Seidman Cancer Center at Lake Health Mentor Campus

Address:
City: Mentor
Zip: 44060
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 800-641-2422
Email: CTUReferral@UHhospitals.org

Investigator:
Last name: Alberto J. Montero
Email: Principal Investigator

Facility:
Name: Knox Community Hospital

Address:
City: Mount Vernon
Zip: 43050
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 614-488-2745
Email: Jeffh@columbusccop.org

Investigator:
Last name: William A. Wilson
Email: Principal Investigator

Facility:
Name: Licking Memorial Hospital

Address:
City: Newark
Zip: 43055
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 614-488-2745
Email: Jeffh@columbusccop.org

Investigator:
Last name: William A. Wilson
Email: Principal Investigator

Facility:
Name: Mercy Health Perrysburg Cancer Center

Address:
City: Perrysburg
Zip: 43551
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 614-488-2745
Email: Jeffh@columbusccop.org

Investigator:
Last name: William A. Wilson
Email: Principal Investigator

Facility:
Name: Southern Ohio Medical Center

Address:
City: Portsmouth
Zip: 45662
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 614-488-2745
Email: Jeffh@columbusccop.org

Investigator:
Last name: William A. Wilson
Email: Principal Investigator

Facility:
Name: Springfield Regional Cancer Center

Address:
City: Springfield
Zip: 45504
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 614-488-2745
Email: Jeffh@columbusccop.org

Investigator:
Last name: William A. Wilson
Email: Principal Investigator

Facility:
Name: Springfield Regional Medical Center

Address:
City: Springfield
Zip: 45504
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 614-488-2745
Email: Jeffh@columbusccop.org

Investigator:
Last name: William A. Wilson
Email: Principal Investigator

Facility:
Name: Mercy Health - Saint Anne Hospital

Address:
City: Toledo
Zip: 43623
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 614-488-2745
Email: Jeffh@columbusccop.org

Investigator:
Last name: William A. Wilson
Email: Principal Investigator

Facility:
Name: Upper Valley Medical Center

Address:
City: Troy
Zip: 45373
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 937-528-2900
Email: clinical.trials@daytonncorp.org

Investigator:
Last name: Michael S. Guy
Email: Principal Investigator

Facility:
Name: Saint Ann's Hospital

Address:
City: Westerville
Zip: 43081
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 614-488-2745
Email: Jeffh@columbusccop.org

Investigator:
Last name: William A. Wilson
Email: Principal Investigator

Facility:
Name: Genesis Healthcare System Cancer Care Center

Address:
City: Zanesville
Zip: 43701
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 614-488-2745
Email: Jeffh@columbusccop.org

Investigator:
Last name: William A. Wilson
Email: Principal Investigator

Facility:
Name: University of Oklahoma Health Sciences Center

Address:
City: Oklahoma City
Zip: 73104
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 405-271-8777
Email: ou-clinical-trials@ouhsc.edu

Investigator:
Last name: Lauren E. Dockery
Email: Principal Investigator

Facility:
Name: Providence Newberg Medical Center

Address:
City: Newberg
Zip: 97132
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 503-215-2614
Email: CanRsrchStudies@providence.org

Investigator:
Last name: Dan S. Zuckerman
Email: Principal Investigator

Facility:
Name: Saint Alphonsus Cancer Care Center-Ontario

Address:
City: Ontario
Zip: 97914
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 406-969-6060
Email: mccinfo@mtcancer.org

Investigator:
Last name: John M. Schallenkamp
Email: Principal Investigator

Facility:
Name: Providence Willamette Falls Medical Center

Address:
City: Oregon City
Zip: 97045
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 503-215-2614
Email: CanRsrchStudies@providence.org

Investigator:
Last name: Dan S. Zuckerman
Email: Principal Investigator

Facility:
Name: Providence Portland Medical Center

Address:
City: Portland
Zip: 97213
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 503-215-2614
Email: CanRsrchStudies@providence.org

Investigator:
Last name: Dan S. Zuckerman
Email: Principal Investigator

Facility:
Name: Providence Saint Vincent Medical Center

Address:
City: Portland
Zip: 97225
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 503-215-2614
Email: CanRsrchStudies@providence.org

Investigator:
Last name: Dan S. Zuckerman
Email: Principal Investigator

Facility:
Name: Lehigh Valley Hospital-Cedar Crest

Address:
City: Allentown
Zip: 18103
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 610-402-9543
Email: Morgan_M.Horton@lvhn.org

Investigator:
Last name: Tareq Al baghdadi
Email: Principal Investigator

Facility:
Name: UPMC Altoona

Address:
City: Altoona
Zip: 16601
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 412-339-5294
Email: Roster@nrgoncology.org

Investigator:
Last name: Alexander B. Olawaiye
Email: Principal Investigator

Facility:
Name: Lehigh Valley Hospital - Muhlenberg

Address:
City: Bethlehem
Zip: 18017
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 610-402-9543
Email: Morgan_M.Horton@lvhn.org

Investigator:
Last name: Tareq Al baghdadi
Email: Principal Investigator

Facility:
Name: Bryn Mawr Hospital

Address:
City: Bryn Mawr
Zip: 19010
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 484-476-2649
Email: turzoe@mlhs.org

Investigator:
Last name: Paul B. Gilman
Email: Principal Investigator

Facility:
Name: Pocono Medical Center

Address:
City: East Stroudsburg
Zip: 18301
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 610-402-9543
Email: Morgan_M.Horton@lvhn.org

Investigator:
Last name: Tareq Al baghdadi
Email: Principal Investigator

Facility:
Name: UPMC Hillman Cancer Center Erie

Address:
City: Erie
Zip: 16505
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 412-389-5208
Email: haneydl@upmc.edu

Investigator:
Last name: Alexander B. Olawaiye
Email: Principal Investigator

Facility:
Name: UPMC Cancer Centers - Arnold Palmer Pavilion

Address:
City: Greensburg
Zip: 15601
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 724-838-1900

Investigator:
Last name: Alexander B. Olawaiye
Email: Principal Investigator

Facility:
Name: UPMC Hillman Cancer Center at Rocco And Nancy Ortenzio Cancer Pavilion

Address:
City: Mechanicsburg
Zip: 17050
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 412-389-5208
Email: haneydl@upmc.edu

Investigator:
Last name: Alexander B. Olawaiye
Email: Principal Investigator

Facility:
Name: Riddle Memorial Hospital

Address:
City: Media
Zip: 19063
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 484-476-2649
Email: turzoe@mlhs.org

Investigator:
Last name: Paul B. Gilman
Email: Principal Investigator

Facility:
Name: UPMC Hillman Cancer Center - Monroeville

Address:
City: Monroeville
Zip: 15146
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 412-389-5208
Email: haneydl@upmc.edu

Investigator:
Last name: Alexander B. Olawaiye
Email: Principal Investigator

Facility:
Name: Paoli Memorial Hospital

Address:
City: Paoli
Zip: 19301
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 484-476-2649
Email: turzoe@mlhs.org

Investigator:
Last name: Paul B. Gilman
Email: Principal Investigator

Facility:
Name: Pennsylvania Hospital

Address:
City: Philadelphia
Zip: 19107
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 855-216-0098
Email: PennCancerTrials@careboxhealth.com

Investigator:
Last name: Patricia A. Locantore-Ford
Email: Principal Investigator

Facility:
Name: Thomas Jefferson University Hospital

Address:
City: Philadelphia
Zip: 19107
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 215-600-9151
Email: ONCTrialNow@jefferson.edu

Investigator:
Last name: Mitchell I. Edelson
Email: Principal Investigator

Facility:
Name: Fox Chase Cancer Center

Address:
City: Philadelphia
Zip: 19111
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 215-728-4790

Investigator:
Last name: Angela Jain
Email: Principal Investigator

Facility:
Name: University of Pittsburgh Cancer Institute (UPCI)

Address:
City: Pittsburgh
Zip: 15232
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 412-647-8073

Investigator:
Last name: Alexander B. Olawaiye
Email: Principal Investigator

Facility:
Name: UPMC-Passavant Hospital

Address:
City: Pittsburgh
Zip: 15237
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 412-367-6454

Investigator:
Last name: Alexander B. Olawaiye
Email: Principal Investigator

Facility:
Name: Asplundh Cancer Pavilion

Address:
City: Willow Grove
Zip: 19090
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 215-600-9151
Email: ONCTrialNow@jefferson.edu

Investigator:
Last name: Mitchell I. Edelson
Email: Principal Investigator

Facility:
Name: Lankenau Medical Center

Address:
City: Wynnewood
Zip: 19096
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 484-476-2649
Email: turzoe@mlhs.org

Investigator:
Last name: Paul B. Gilman
Email: Principal Investigator

Facility:
Name: Women and Infants Hospital

Address:
City: Providence
Zip: 02905
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 401-274-1122

Investigator:
Last name: Matthew T. Oliver
Email: Principal Investigator

Facility:
Name: Rapid City Regional Hospital

Address:
City: Rapid City
Zip: 57701
Country: United States

Status: Active, not recruiting

Facility:
Name: Sanford Cancer Center Oncology Clinic

Address:
City: Sioux Falls
Zip: 57104
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 605-312-3320
Email: OncologyClinicTrialsSF@sanfordhealth.org

Investigator:
Last name: Maria C. Bell
Email: Principal Investigator

Facility:
Name: Sanford USD Medical Center - Sioux Falls

Address:
City: Sioux Falls
Zip: 57117-5134
Country: United States

Status: Suspended

Facility:
Name: MD Anderson in The Woodlands

Address:
City: Conroe
Zip: 77384
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 866-632-6789
Email: askmdanderson@mdanderson.org

Investigator:
Last name: Shannon N. Westin
Email: Principal Investigator

Facility:
Name: M D Anderson Cancer Center

Address:
City: Houston
Zip: 77030
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 877-632-6789
Email: askmdanderson@mdanderson.org

Investigator:
Last name: Shannon N. Westin
Email: Principal Investigator

Facility:
Name: MD Anderson West Houston

Address:
City: Houston
Zip: 77079
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 877-632-6789
Email: askmdanderson@mdanderson.org

Investigator:
Last name: Shannon N. Westin
Email: Principal Investigator

Facility:
Name: MD Anderson League City

Address:
City: League City
Zip: 77573
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 877-632-6789
Email: askmdanderson@mdanderson.org

Investigator:
Last name: Shannon N. Westin
Email: Principal Investigator

Facility:
Name: MD Anderson in Sugar Land

Address:
City: Sugar Land
Zip: 77478
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 877-632-6789
Email: askmdanderson@mdanderson.org

Investigator:
Last name: Shannon N. Westin
Email: Principal Investigator

Facility:
Name: Virginia Cancer Institute

Address:
City: Richmond
Zip: 23229
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 804-287-3000
Email: smoore@vacancer.com

Investigator:
Last name: Chelsea Salyer
Email: Principal Investigator

Facility:
Name: VCU Massey Cancer Center at Stony Point

Address:
City: Richmond
Zip: 23235
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact
Email: ctoclinops@vcu.edu

Investigator:
Last name: Chelsea Salyer
Email: Principal Investigator

Facility:
Name: Virginia Commonwealth University/Massey Cancer Center

Address:
City: Richmond
Zip: 23298
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact
Email: CTOclinops@vcu.edu

Investigator:
Last name: Chelsea Salyer
Email: Principal Investigator

Facility:
Name: Carilion Clinic Gynecological Oncology

Address:
City: Roanoke
Zip: 24016
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 540-985-8510

Investigator:
Last name: Chelsea Salyer
Email: Principal Investigator

Facility:
Name: VCU Community Memorial Health Center

Address:
City: South Hill
Zip: 23970
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact
Email: nemer.elmouallem@vcuhealth.org

Investigator:
Last name: Chelsea Salyer
Email: Principal Investigator

Facility:
Name: Swedish Cancer Institute-Edmonds

Address:
City: Edmonds
Zip: 98026
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 206-215-3086
Email: PCRC-NCORP@Swedish.org

Investigator:
Last name: Dan S. Zuckerman
Email: Principal Investigator

Facility:
Name: Swedish Cancer Institute-Issaquah

Address:
City: Issaquah
Zip: 98029
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 206-215-3086
Email: PCRC-NCORP@Swedish.org

Investigator:
Last name: Dan S. Zuckerman
Email: Principal Investigator

Facility:
Name: Valley Medical Center

Address:
City: Renton
Zip: 98055
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 425-228-3440
Email: research@valleymed.org

Investigator:
Last name: John A. Ellerton
Email: Principal Investigator

Facility:
Name: Swedish Medical Center-First Hill

Address:
City: Seattle
Zip: 98122
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 206-215-3086
Email: PCRC-NCORP@Swedish.org

Investigator:
Last name: Dan S. Zuckerman
Email: Principal Investigator

Facility:
Name: North Star Lodge Cancer Center at Yakima Valley Memorial Hospital

Address:
City: Yakima
Zip: 98902
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 509-574-3535
Email: Memorial-ClinicalTrials@yvmh.org

Investigator:
Last name: John A. Ellerton
Email: Principal Investigator

Facility:
Name: Edwards Comprehensive Cancer Center

Address:
City: Huntington
Zip: 25701
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 304-399-6566
Email: Christina.Cole@chhi.org

Investigator:
Last name: Toni O. Pacioles
Email: Principal Investigator

Facility:
Name: West Virginia University Healthcare

Address:
City: Morgantown
Zip: 26506
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 304-293-7374
Email: cancertrialsinfo@hsc.wvu.edu

Investigator:
Last name: Krista S. Pfaendler
Email: Principal Investigator

Facility:
Name: Duluth Clinic Ashland

Address:
City: Ashland
Zip: 54806
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 218-786-3308
Email: CancerTrials@EssentiaHealth.org

Investigator:
Last name: Bret E. Friday
Email: Principal Investigator

Facility:
Name: Aurora Cancer Care-Southern Lakes VLCC

Address:
City: Burlington
Zip: 53105
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 414-302-2304
Email: ncorp@aurora.org

Investigator:
Last name: Antony Ruggeri
Email: Principal Investigator

Facility:
Name: Aurora Saint Luke's South Shore

Address:
City: Cudahy
Zip: 53110
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 414-302-2304
Email: ncorp@aurora.org

Investigator:
Last name: Antony Ruggeri
Email: Principal Investigator

Facility:
Name: Aurora Health Care Germantown Health Center

Address:
City: Germantown
Zip: 53022
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 414-302-2304
Email: ncorp@aurora.org

Investigator:
Last name: Antony Ruggeri
Email: Principal Investigator

Facility:
Name: Aurora Cancer Care-Grafton

Address:
City: Grafton
Zip: 53024
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 414-302-2304
Email: ncorp@aurora.org

Investigator:
Last name: Antony Ruggeri
Email: Principal Investigator

Facility:
Name: Saint Vincent Hospital Cancer Center Green Bay

Address:
City: Green Bay
Zip: 54301
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 920-433-8889
Email: ewd_research_admin@hshs.org

Investigator:
Last name: Matthew L. Ryan
Email: Principal Investigator

Facility:
Name: Saint Vincent Hospital Cancer Center at Saint Mary's

Address:
City: Green Bay
Zip: 54303
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 920-433-8889
Email: ewd_research_admin@hshs.org

Investigator:
Last name: Matthew L. Ryan
Email: Principal Investigator

Facility:
Name: Aurora BayCare Medical Center

Address:
City: Green Bay
Zip: 54311
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 414-302-2304
Email: ncorp@aurora.org

Investigator:
Last name: Antony Ruggeri
Email: Principal Investigator

Facility:
Name: Aurora Cancer Care-Kenosha South

Address:
City: Kenosha
Zip: 53142
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 414-302-2304
Email: ncorp@aurora.org

Investigator:
Last name: Antony Ruggeri
Email: Principal Investigator

Facility:
Name: Gundersen Lutheran Medical Center

Address:
City: La Crosse
Zip: 54601
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 608-775-2385
Email: cancerctr@gundersenhealth.org

Investigator:
Last name: Collin D. Driscoll
Email: Principal Investigator

Facility:
Name: University of Wisconsin Carbone Cancer Center - Eastpark Medical Center

Address:
City: Madison
Zip: 53718
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 800-622-8922
Email: clinicaltrials@cancer.wisc.edu

Investigator:
Last name: Janelle Sobecki
Email: Principal Investigator

Facility:
Name: University of Wisconsin Carbone Cancer Center - University Hospital

Address:
City: Madison
Zip: 53792
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 800-622-8922
Email: clinicaltrials@cancer.wisc.edu

Investigator:
Last name: Janelle Sobecki
Email: Principal Investigator

Facility:
Name: Aurora Bay Area Medical Group-Marinette

Address:
City: Marinette
Zip: 54143
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 414-302-2304
Email: ncorp@aurora.org

Investigator:
Last name: Antony Ruggeri
Email: Principal Investigator

Facility:
Name: Aurora Cancer Care-Milwaukee

Address:
City: Milwaukee
Zip: 53209
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 414-302-2304
Email: ncorp@aurora.org

Investigator:
Last name: Antony Ruggeri
Email: Principal Investigator

Facility:
Name: Aurora Saint Luke's Medical Center

Address:
City: Milwaukee
Zip: 53215
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 414-302-2304
Email: ncorp@aurora.org

Investigator:
Last name: Antony Ruggeri
Email: Principal Investigator

Facility:
Name: Aurora Sinai Medical Center

Address:
City: Milwaukee
Zip: 53233
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 414-302-2304
Email: ncorp@aurora.org

Investigator:
Last name: Antony Ruggeri
Email: Principal Investigator

Facility:
Name: Saint Vincent Hospital Cancer Center at Oconto Falls

Address:
City: Oconto Falls
Zip: 54154
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 920-433-8889
Email: ewd_research_admin@hshs.org

Investigator:
Last name: Matthew L. Ryan
Email: Principal Investigator

Facility:
Name: Vince Lombardi Cancer Clinic - Oshkosh

Address:
City: Oshkosh
Zip: 54904
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 414-302-2304
Email: ncorp@aurora.org

Investigator:
Last name: Antony Ruggeri
Email: Principal Investigator

Facility:
Name: Aurora Cancer Care-Racine

Address:
City: Racine
Zip: 53406
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 414-302-2304
Email: ncorp@aurora.org

Investigator:
Last name: Antony Ruggeri
Email: Principal Investigator

Facility:
Name: Saint Vincent Hospital Cancer Center at Sheboygan

Address:
City: Sheboygan
Zip: 53081
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 920-433-8889
Email: ewd_research_admin@hshs.org

Investigator:
Last name: Matthew L. Ryan
Email: Principal Investigator

Facility:
Name: Vince Lombardi Cancer Clinic-Sheboygan

Address:
City: Sheboygan
Zip: 53081
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 414-302-2304
Email: ncorp@aurora.org

Investigator:
Last name: Antony Ruggeri
Email: Principal Investigator

Facility:
Name: Saint Vincent Hospital Cancer Center at Sturgeon Bay

Address:
City: Sturgeon Bay
Zip: 54235-1495
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 920-433-8889
Email: ewd_research_admin@hshs.org

Investigator:
Last name: Matthew L. Ryan
Email: Principal Investigator

Facility:
Name: Aurora Medical Center in Summit

Address:
City: Summit
Zip: 53066
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 414-302-2304
Email: ncorp@aurora.org

Investigator:
Last name: Antony Ruggeri
Email: Principal Investigator

Facility:
Name: Vince Lombardi Cancer Clinic-Two Rivers

Address:
City: Two Rivers
Zip: 54241
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 414-302-2304
Email: ncorp@aurora.org

Investigator:
Last name: Antony Ruggeri
Email: Principal Investigator

Facility:
Name: Aurora Cancer Care-Milwaukee West

Address:
City: Wauwatosa
Zip: 53226
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 414-302-2304
Email: ncorp@aurora.org

Investigator:
Last name: Antony Ruggeri
Email: Principal Investigator

Facility:
Name: Aurora West Allis Medical Center

Address:
City: West Allis
Zip: 53227
Country: United States

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 414-302-2304
Email: ncorp@aurora.org

Investigator:
Last name: Antony Ruggeri
Email: Principal Investigator

Facility:
Name: Puerto Rico Hematology Oncology Group

Address:
City: Bayamon
Zip: 00961
Country: Puerto Rico

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 787-780-2865

Investigator:
Last name: Luis J. Santos Reyes
Email: Principal Investigator

Facility:
Name: Centro Comprensivo de Cancer de UPR

Address:
City: San Juan
Zip: 00927
Country: Puerto Rico

Status: Recruiting

Contact:
Last name: Site Public Contact

Phone: 412-339-5294
Email: Roster@nrgoncology.org

Investigator:
Last name: Luis J. Santos Reyes
Email: Principal Investigator

Start date: April 25, 2023

Completion date: October 1, 2028

Lead sponsor:
Agency: National Cancer Institute (NCI)
Agency class: NIH

Collaborator:
Agency: NRG Oncology
Agency class: Other

Source: National Cancer Institute (NCI)

Record processing date: ClinicalTrials.gov processed this data on November 12, 2024

Source: ClinicalTrials.gov page: https://clinicaltrials.gov/ct2/show/NCT05554328